Found 23 matching trials
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers PHASE2 This clinical trial is looking at a drug called alectinib. Alectinib is app...
Show More Location
Belfast City Hospital
Learn More & Join Trial
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors PHASE1 This is a two-part Phase 1, open label, multi-center, single arm, non-rando...
Show More Location
UCSF Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer NA Lung cancer is diagnosed at metastatic stage in 60% of the cases. For these...
Show More Location
Centre Hospitalier de Bayeux
Learn More & Join Trial
Precision Medicine for Immunotherapy-Resistant Advanced Esophageal Cancer PHASE2 This study is an open-label, biomarker-integrated umbrella trial designed t...
Show More Location
Multiple Locations
Learn More & Join Trial
BCL6-rearrangements Implications in Non-Hodgkin Lymphomas. N/A Non-Hodgkin lymphomas (NHLs) constitute a heterogeneous group of malignant ...
Show More Location
Hopital Lyon Sud - HCL
Learn More & Join Trial
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers. PHASE2 This clinical trial is looking at a drug called entrectinib. Entrectinib is...
Show More Location
Belfast City Hospital
Learn More & Join Trial
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors PHASE1 * To evaluate the safety and tolerability of escalating doses of ERAS-601 w...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol PHASE2 DETERMINE is an open-label phase II/III trial. It will look at targeted tre...
Show More Location
Belfast City Hospital
Learn More & Join Trial
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations PHASE2 This clinical trial is looking at a combination of drugs called trastuzumab...
Show More Location
Belfast City Hospital
Learn More & Join Trial
SLPI for Prostate Cancer N/A Exploratory study of SLPI expression in human prostate cancer patients This...
Show More Location
Careggi University Hospital
Learn More & Join Trial